You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Blood Brain Barrier (BBB) Permeable Encapsulating Agents for Effective Delivery of CNS-active Agents
SBC: LYNNTECH INC. Topic: CBD08107Drug transport in the central nervous system is highly regulated by the Blood-Brain Barrier (BBB). Most medicines, including many for treating cancer, Alzheimer’s, and stroke, do not meet essential criteria, such as lipophilicity and low molecular weight, required for appreciable transport into the brain. However, endogenous peptides, such as insulin or transferrin, and certain monoclonal anti ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Collective Protection for Military Working Dogs
SBC: AGAVE BIOSYSTEMS INC. Topic: CBD08103Shelter enclosures for military working dogs in the event of a CB attack is a technology gap identified by the Joint Requirements Office. Important parameters to consider in the design of protective enclosures include low weight and size to minimize transport requirements; rapid setup; and accommodation of canine physiological and psychological comfort needs. The overall operational weight of th ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Combined Dielectrophoretic Microfluidic System
SBC: Physical Optics Corporation Topic: CBD08101To address the U.S. Army CBD need for a high resolution system whereby proteins present in a complex mixture can be rapidly and reproducibly separated, Physical Optics Corporation (POC) proposes to develop a new Combined Dielectrophoretic Microfluidic (CDM) System based on the integration of electrodeless dielectrophoresis and dynamic isoelectric focusing techniques, used to carry out two-dimensio ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Dynamic Multicomponent Optical Analyzer for Chemical Weapon (CW) Exposure Studies
SBC: Los Gatos Research Topic: CBD08104In this SBIR Phase I effort, Los Gatos Research (LGR) proposes to design, develop and test a novel laser-based gas analyzer optimized for chemical weapon exposure studies based on cavity enhanced absorption in the mid-infrared spectral region. This analyzer will provide sensitive and accurate quantification of several chemical weapons through real-time measurements of high-resolution absorption s ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Dynamic Multicomponent Optical Analyzer for Chemical Weapon (CW) Exposure Studies
SBC: SCIENCE & ENGINEERING SERVICES, INC. Topic: CBD08104We propose to build a compact laser photoacoustic spectrometric (LPAS) sensor for continuous, real-time broadband analysis of multiple chemical components, and perform field tests to qualify it for dynamic monitoring of chemical warfare agents (CWA). Our sensor will be based on our laboratory LPAS instrument (at technology readiness level TRL-4) that has already demonstrated successful multicompon ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Handheld IR Raman Spectroscopy for Rapid Chemical Identification
SBC: Aerius Photonics, LLC. Topic: CBD08102Aerius Photonics and partner Ahura Scientific, propose to develop a handheld system, based on Ahura’s successful FirstDefender Raman system, that employs an excitation laser emitting at 980 nm and a low noise InGaAs array based on Aerius’ high performance InGaAs technology. This system will substantially reduce the fluorescence present in CCD-based systems, and unmask otherwise obscured spect ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Multiple Indication Adjuvants
SBC: BIOPROTECTION SYSTEMS CORP. Topic: CBD08105The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vaccine candidates for the select Category A viral pathogens Zaire ebolavirus (ZEBOV, filovirus), Rift Valley fever virus (RVFV, bunyavirus), and Lassa virus (LV, arenavirus), to evaluate the adjuvant pot ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Oligonucleotide Enzyme Surrogate (OnES)
SBC: Accacia International LLC Topic: CBD08108Historically organophosphorus compounds such as insecticides and nerve agents have been susceptible to decomposition by proteinaceous enzymes. Organophosphate hydrolases (OPH) represent a practical method to deactivate such compounds peripherally and on surfaces. However, when such organophosphates are ingested, the use of proteinaceous enzymes such as OPH can be problematic because of their tende ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Ribozymes for In Vivo Degradation of G-Nerve Agents
SBC: AGAVE BIOSYSTEMS INC. Topic: CBD08108Given the possibility to administer prophylactic doses of protein bioscavengers inactivating OP nerve agents before they reach their acetylcholinesterase target, much attention has been given to proteins such as human butyrylcholinesterase and paraoxonase I. As small nucleic acid catalysts can exhibit triphosphoesterase activities, the identification of new molecules active against nerve agents w ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Sequential Isoelectric Point Separation of Proteins Using Non-Gel, Microfluidic System
SBC: LYNNTECH INC. Topic: CBD08101The measurement of biochemical changes within the human body can provide a means to monitor a person’s physiological health. Many of the biochemicals that provide a snapshot of a person’s health are proteins. The challenge with measuring proteins is the existence of approximately ten orders of magnitude difference in concentration between the most abundant proteins in blood and those typically ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense